Federal Court Again Rules that Genes Can be Patented
Tuesday, August 21, 2012
The biotech industry breathed a sigh of relief last week when a federal court again upheld companies’ ability to patent human genes.
Civil libertarians have challenged the industry, starting with Myriad Genetics, arguing that to own a patent involving human genetic material is the same as patenting “products of nature,” which is illegal.
The American Civil Liberties Union (ACLU) won its first case in 2010, when it sued to nullify Myriad Genetics’ patents on the BRCA-1 BRCA-2 genes, which can help detect breast cancer.
The company last year appealed to a federal appellate court and won a decision affirming its patents.
It was then the ACLU’s turn to appeal to the U.S. Supreme Court. But the high court refused to hear the case and bumped it back to a federal appeals court. There, a three-judge panel upheld the previous appellate decision that left Myriad Genetics’ patents in place.
In a 2-to1 decision, the judges ruled that “isolated” human genes are patentable.
To Learn More:
U.S. Court Upholds Status Quo on Gene Patents (by Amanda Wilson, Inter Press Service)
Federal Court Approves Patenting of Human Genes (by David Wallechinsky, AllGov)
- Top Stories
- Unusual News
- Where is the Money Going?
- U.S. and the World
- Appointments and Resignations
- Latest News
- Because Obama Administration Demanded Google Cooperate in Surveillance, Chinese Gained Access to Targets
- 85,000 Vets Treated for Sexual Abuse Injuries and Trauma in 2012
- U.S. Counter-Terrorism Apparatus is used to Quell Dissent among Americans
- Global Increase in Bigotry against Jews and Muslims
- Robots Seen as Filling Caregiver Vacuum for Aging Baby Boomers